Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 518 for your search:
Cancer Type/Condition:  Myelodysplastic syndromes
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 60
Sponsor: Other
Protocol IDs: AML-elderly 01/99 Trial, NCT00199147

2.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H0901329, NCT01189409

3.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-038, NCT01200355

4.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: Par 06-0045, NCT01313247

5.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 21 and under
Sponsor: Other
Protocol IDs: TASMC-11-MB-442-CTIL, NCT01339988

6.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 10 to 90
Sponsor: Other
Protocol IDs: MST/MDS-307PLAH-ASH, NCT01674985

7.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 40 to 60
Sponsor: Other
Protocol IDs: 2013-08, NCT01856803

8.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Active
Age: 1 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 200170, NCT01957176

9.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DREAM-201, NCT02013102

10.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML29005, NCT02145026

11.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 months to 21 years
Sponsor: Other
Protocol IDs: #1R01FD003410-01, R01 FD003410-01-A1, NCT00999713

12.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 0 to 18
Sponsor: Other
Protocol IDs: CHU-0060, NCT01007617

13.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H-4-2010-046, NCT01404520

14.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 16 to 80
Sponsor: Other
Protocol IDs: CHG-DAC 001, SHDC12010202, NCT01417767

15.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: Busulfan-2013, NCT01800643

16.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 15242, H9H-MC-JBAV, 2013-003235-30, NCT02008318

17.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: KMC01-35-12, NCT02042482

18.

Phase: Phase III
Type: Treatment
Status: Active
Age: 54 and under
Sponsor: Other
Protocol IDs: 0107M05202, MT2001-02, NCT00176930

19.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 15 to 79
Sponsor: Other
Protocol IDs: C-SHOT 0402, NCT00137787

20.

Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SCT 0307, NCT00619879

21.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PB-PG-0107-11134, ISRCTN04119516, NCT00678405

22.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: RICMAC, EBMT 42205525, NCT00682396

23.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0808, NCI-2012-01673, NCT00761618

24.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: MC-FludT.14/L, EudraCT-No.: 2008-002356-18, NCT00822393

25.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01173, CDR0000634119, ECOG-E2905, E2905, U10CA180820, U10CA021115, NCT00843882
1     
New Search